Global Nutrigenomics Testing Market Size, Trends and Growth Opportunity, By Test Type (food intolerance tests, cardiometabolic health tests, weight management tests, gluten intolerance tests, and vitamin tests), By Technology Type (Next Generation Sequencing, Real Time PCR, DNA Microarray, and Sanger Sequencing), By Sample Type (Buccal Swab Sample, Saliva Sample, Blood Sample), By Application Type (Metabolic Disorder, Cancer, Cardiovascular System Diseases, and Sports and Nutrition), By End User (Hospital, Nutrition Clinics, and Diagnostics Laboratory), By Region and Forecast Till 2027.
Global Nutrigenomics Testing Market
The global nutrigenomics testing market was valued at USD 255.20 million in 2021, and it is expected to reach USD 1,086 million by 2027, at a CAGR of 18.45%.
Nutrogenomics is the study of the interactions between genes, nutrition, and health. Nutrigenomics is used to understand how food interacts with specific genes. Over the projection period, the global market for nutrigenomics testing will rise due to the rising role of food in diseases like cancer, cardiovascular disease, and metabolic diseases. The large target market for nutrigenomics testing, which is affected by these disorders, is the elderly population. On the other hand, the global market for nutrigenomics testing will expand due to government policies that fund molecular research and ongoing technological improvements.
Market Drivers
The main factor anticipated to fuel the growth of the global nutrigenomics testing market is the rise in knowledge of the connection between genes, nutrition, and health. A further factor driving the demand for nutrigenomics testing in the market is the rise in the prevalence of metabolic illnesses such as obesity, cardiovascular disease, diabetes, and cancer in developing nations. Additionally, personalized diet and genetic nutrition profile are significant trends, and an increase in demand and popularity for these elements would have a positive impact on the growth of the global nutrigenomics testing market.
Market Restraints
The market's restricting aspect, which is anticipated to restrain the growth of the worldwide nutrigenomics testing market, is a lack of understanding of the application and cost of nutrigenomics. Also, the absence of cutting-edge genomics technology and genomic research in underdeveloped nations is anticipated to restrain the expansion of the global market for nutrigenomics testing.
Market Segmentation
The global nutrigenomics testing market is segmented into test type, technology type, sample type, application type, and end user. By test type, the market is segmented into food intolerance tests, cardiometabolic health tests, weight management tests, gluten intolerance tests, and vitamin tests. By technology type, the market is segmented into Next Generation Sequencing, Real Time PCR, DNA Microarray, and Sanger Sequencing. By sample type, the market is segmented into buccal swab samples, saliva samples, and blood samples. By application, the market is segmented into metabolic disorders, cancer, cardiovascular system diseases, sports nutrition, and others. By end user, the market is segmented into hospitals, nutrition clinics, and diagnostic laboratories.
Regional Analysis 
The global nutrigenomics testing market is segmented into five regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The market for nutrigenomics testing in North America is being propelled by reasons such as the rise in chronic illness prevalence, rising healthcare expenses, and an escalating desire for tailored therapy. The existence of significant market participants in the area, established healthcare infrastructure, and technological developments in genetic testing are further factors driving the industry.
Market Key Players
Various key players are discussed in this report such as , Salugen, X code life, Interleukin Genetics, NutraGene, Metagenics, CURA INTEGRATIVE MEDICINE,Nutrigenomix, , Gene Box, Sanger Genomics, Holistic Heal, GX Sciences, Inc., Pathway Genomics, and Cura Integrative Medicine.
Market Taxonomy 
By Test Type
• Food intolerances test
• Cardiometabolic health test
• Weight-management
• Gluten intolerance test
• Vitamin Test
By Technology Type
• Next-generation sequencing
• Real-time PCR
• DNA microarray
• Sanger Sequencing
By Sample Type
• Buccal Swab Sample 
• Saliva Sample 
• Blood Sample 
By Application Type
• Metabolic Disorders
• Cancer
• Cardiovascular System Diseases
• Sport and Nutrition
By End User
• Hospital
• Nutrition Clinics
• Diagnostics Laboratories
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Key Question Addressed by the Report
What are the Key Opportunities in Global Nutrigenomics Testing Market?
What will be the growth rate from 2022 to 2027?
Which segment/region will have highest growth?
What are the factors that will impact/drive the Market?
What is the role of key players in the value chain?
 

Global Nutrigenomics Testing Market TOC:
1.  Executive Summary
1.1. Market Taxonomy
2. Global Nutrigenomics Testing Market Demand (in Value or Size in US$ Mn) Analysis and Forecast
3.  Market Background
3.1. Forecast Factor
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Challenges
3.2.3. Trends
4. Global Nutrigenomics Testing Market Snapshot
5. Global Nutrigenomics Testing Market Analysis, By Test Type 
5.1. Y-o-Y Growth Comparison, By Test Type 
5.2. Global Nutrigenomics Testing Market Share Analysis, By Test Type 
5.3. Global Nutrigenomics Testing Market Size and Forecast, By Test Type 
5.3.1 Food Intolerances Test
5.3.2 Cardiometabolic Health Test
5.3.3 Weight Management
5.3.4 Gluten Intolerance Test
5.3.5 Vitamin Test
6. Global Nutrigenomics Testing Market Analysis, By Technology Type
6.1. Y-o-Y Growth Comparison, By Technology Type
6.2. Global Nutrigenomics Testing Market Share Analysis, By Technology Type
6.3. Global Nutrigenomics Testing Market Size and Forecast, By Technology Type
6.3.1Next Generation Sequencing
6.3.2 Real-time PCR
6.3.3DNA Microarray
6.3.4 Sanger Sequencing
7.   Global Nutrigenomics Testing Market Analysis, By Sample Type
7.1. Y-o-Y Growth Comparison, By Sample Type
7.2. Global Nutrigenomics Testing Market Share Analysis, By Sample Type
7.3. Global Nutrigenomics Testing Market Size and Forecast, By Sample Type 
7.3.1 Buccal Swab Sample
7.3.2 Saliva Sample
7.3.3 Blood Sample
8.   Global Nutrigenomics Testing Market Analysis, By Application
8.1. Y-o-Y Growth Comparison, By Application
8.2. Global Nutrigenomics Testing Market Share Analysis, By Application
8.3. Global Nutrigenomics Testing Market Size and Forecast, By Application
8.3.1 Metabolic Disorders
8.3.2 Cancer
8.3.3 Cardiovascular System Disease 
8.3.4 Sport and Nutrition
9.  Global Nutrigenomics Testing Market Analysis, By End User
9.1. Y-o-Y Growth Comparison, By End User
9.2. Global Nutrigenomics Testing Market Share Analysis, By End User
9.3. Global Nutrigenomics Testing Market Size and Forecast, By End User
9.3.1 Hospital
9.3.2 Nutritional Clinics
9.3.3 Diagnostic Laboratories
10. Global Nutrigenomics Testing Market Analysis, By Region
10.1. Y-o-Y Growth Comparison, By Region
10.2. Global Nutrigenomics Testing Market Share Analysis, By Region
11.North America Nutrigenomics Testing Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 North America Nutrigenomics Testing Market Analysis, By Test Type 
11.3 North America Nutrigenomics Testing Market Analysis, By Technology Type
11.4 North America Nutrigenomics Testing Market Analysis, By Sample Type
11.5 North America Nutrigenomics Testing Market Analysis, By Application
11.6 North America Nutrigenomics Testing Market Analysis, By End User
11.7 North America Nutrigenomics Testing Market Analysis, By Country
11.7.1USA
11.7.2 Canada
11.7.3 Mexico
12. Europe Nutrigenomics Testing Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Europe Nutrigenomics Testing Market Analysis, By Test Type 
12.3 Europe Nutrigenomics Testing Market Analysis, By Technology Type
12.4 Europe Nutrigenomics Testing Market Analysis, By Sample Type
12.5 Europe Nutrigenomics Testing Market Analysis, By Application
12.6 Europe Nutrigenomics Testing Market Analysis, By End User
12.7 Europe Nutrigenomics Testing Market Analysis, By Country
12.7 .1Germany
12.7 .2 France
12.7 .3 UK
12.7 .4 Rest of Europe
13. Asia Pacific Nutrigenomics Testing Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Asia Pacific Nutrigenomics Testing Market Analysis, By Test Type 
13.3 Asia Pacific Nutrigenomics Testing Market Analysis, By Technology Type
13.4 Asia Pacific Nutrigenomics Testing Market Analysis, By Sample Type
13.5 Asia Pacific Nutrigenomics Testing Market Analysis, By Application
13.6 Asia Pacific Nutrigenomics Testing Market Analysis, End User
13.7 Asia Pacific Nutrigenomics Testing Market Analysis, By Country
13.7.1China
13.7.2 India
13.7.3 Japan
13.7.4 Rest of Asia Pacific
14. Latin America Nutrigenomics Testing Market Analysis and Forecast (2022-2027)
14.1 Introduction
14.2 Latin America Nutrigenomics Testing Market Analysis, By Test Type 
14.3 Latin America Nutrigenomics Testing Market Analysis, By Technology Type
14.4 Latin America Nutrigenomics Testing Market Analysis, By Sample Type
14.5 Latin America Nutrigenomics Testing Market Analysis, by Application
14.6 Latin America Nutrigenomics Testing Market Analysis, End User
15. Middle East & Africa Nutrigenomics Testing Market Analysis and Forecast (2022-2027)
15.1 Introduction
15.2 Middle East & Africa Nutrigenomics Testing Market Analysis, By Test Type 
15.3 Middle East & Africa Nutrigenomics Testing Market Analysis, By Technology Type
15.4 Middle East & Africa Nutrigenomics Testing Market Analysis, By Sample Type
15.5 Middle East & Africa Nutrigenomics Testing Market Analysis, By Application
15.6 Middle East & Africa Nutrigenomics Testing Market Analysis, End User
16. Competition Analysis
16.1 Competition Dashboard
16.2 Market Share Analysis of Top Vendors
16.3 Key Development Strategies
17. Company Profiles
17.1 Salugen
17.1.1 Overview
17.1.2 Offerings
17.1.3 Key Financial
17.1.4 Business Segment & Geographic Overview
17.1.5 Key Market Developments
17.1.6 Key Strategies
17.2 X code life
17.2.1 Overview
17.2.2 Offerings
17.2.3 Key Financial
17.2.4 Business Segment & Geographic Overview
17.2.5 Key Market Developments
17.2.6 Key Strategies
17.3 RFI Ingredients
17.3.1 Overview
17.3.2 Offerings
17.3.3 Key Financial
17.3.4 Business Segment & Geographic Overview
17.3.5 Key Market Developments
17.3.6 Key Strategies
17.4 Interleukin Genetics
17.4.1 Overview
17.4.2 Offerings
17.4.3 Key Financial
17.4.4 Business Segment & Geographic Overview
17.4.5 Key Market Developments
17.4.6 Key Strategies
17.5 NutraGene
17.5.1 Overview
17.5.2 Offerings
17.5.3 Key Financial
17.5.4 Business Segment & Geographic Overview
17.5.5 Key Market Developments
17.5.6 Key Strategies
17.6 Metagenics
17.6.1 Overview
17.6.2 Offerings
17.6.3 Key Financial
17.6.4 Business Segment & Geographic Overview
17.6.5 Key Market Developments
17.6.6 Key Strategies
17.7 CURA INTEGRATIVE MEDICINE
17.7.1 Overview
17.7.2 Offerings
17.7.3 Key Financial
17.7.4 Business Segment & Geographic Overview
17.7.5 Key Market Developments
17.7.6 Key Strategies
17.8 Nutrigenomix,
17.8.1 Overview
17.8.2 Offerings
17.8.3 Key Financial
17.8.4 Business Segment & Geographic Overview
17.8.5 Key Market Developments
17.8.6 Key Strategies
17.9 Gene Box
17.9.1 Overview
17.9.2 Offerings
17.9.3 Key Financial
17.9.4 Business Segment & Geographic Overview
17.9.5 Key Market Developments
17.9.6 Key Strategies
17.10 Sanger Genomics
17.10.1 Overview
17.10.2 Offerings
17.10.3 Key Financial
17.10.4 Business Segment & Geographic Overview
17.10.5 Key Market Developments
17.10.6 Key Strategies
Others
17.11 Holistic Heal
17.12 GX Sciences, Inc
17.13 Pathway Genomics
17.14 Cura Integrative Medicine